1、Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), Volume: 9, Pages: 957-64(in English 964), Journal, 1936. 2、Chemicke Listy pro Vedu a Prumysl, Volume: 37, Pages: 289-90, Journal, 1943. 3、Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer. 4. Drugs Today (Barc). 2018 Sep;54(9):519-533. doi: 10.1358/dot.2018.54.9.2776624. An update on tolvaptan for autosomal dominant polycystic kidney disease. Poch E1, Rodas L2, Blasco M2, Molina A2, Quintana L2. 5.Parameter optimization and process control for the sterilization of ornidazole and sodium chloride injection 6.Physical and pharmacotechnological studies of ornidazole drug 7. Analytical studies for the determination of ornidazole in the presence of degradation products By Visan, Veronica; Ionescu, Mariana S.; Dragos, Mariana; Belu, Dan; Cosofret, Vasile From Revistade Chimie (Bucharest, Romania) (1989), 40(8), 728-31. Language: Romanian, Database: CAPLUS 8. Reactions of nitroimidazoles with free radicals--enhancement of reaction by u.v. irradiation By Moore D E From International journal of radiation biology and related studies in physics, chemistry, and medicine (1985), 47(5),563-8, Language: English, Database: MEDLINE   [更多]

1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels 2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components 3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage 4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors 5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure 6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion 7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema 8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites 9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease 10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement 11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print] 12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print] 13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines 15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing 16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms 17. On the hydrolytic behavior of tinidazole, metronidazole,   [更多]

1.Bulletin of the Chemical Society of Japan, Volume 26, Pages 119-122, Journal, 1953 2.Dalton Transactions 2017,vol. 46, # 5, p. 1510 - 1519 3.Design and evaluation of ophthalmic pharmaceutical products. In Banker GS, Rhodes CT, eds. Modern Pharmaceutics, 4th edn. New York Marcel Dekker, 2002 415-478 4.Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer 5.Journal of Photochemistry and Photobiology, B Biology, Volume 97, Issue 1, Pages 18-21, Journal, 2009 6.Journal of Photochemistry and Photobiology, B Biology, Volume 115, Pages 51-57, Journal; Online Computer File, 2012 7.Nair AD, Lach JL. The kinetics of degradation of chlorobutanol. J Am Pharm Assoc (Sci) 1959; 48 390-395. 8.Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine 9.Plasma?renin?activity-guided strategy for the management of hypertension. 10.Stability of chlorobutanol in aqueous solutions Journal of the American Pharmaceutical Association (1961), Volume 6, Issue 7, July 1966, Pages 372-373 11.Talanta, Volume 146, Pages 732-736, Journal; Online Computer File, 2016   [更多]

文獻(xiàn)標(biāo)題及相關(guān)內(nèi)容： 1. In vitro and in vivo metabolism of rimonabant (SR-141716), a cannabinoid (CB1) receptor antagonist 2. 各種動(dòng)物およびヒトにおける LFP83 の體內(nèi)動(dòng)態(tài) 3. LFP83靜脈內(nèi)投與によるラット分布, 代謝および排泄 4. 34 - Disorders of Blood Cell Production in Clinical Oncology 5. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy   [更多]

文獻(xiàn)標(biāo)題及相關(guān)內(nèi)容： 1.Ohmukai O.Lipo- NSAID preparation[J].Adv Drug Deliv Rev 2.Less pain on injection by a new formulation of propofol? A comparison with propofol LCT 3.Tohno, M.，Konishi , Y.，Kojima , H., Kawahara, K. and Horiba, M. (1992 ) Pharmacokinetics and metabolic studies of LFP83 in man after the single and repeated intravenous administration. Clin. Rep. 26, 3907-3921. 4.Naito, Y. et al.：Arzneim.-Forsch.Drug Res., 46(II), 698-700, 1996 5.What is the Role of NSAIDs in Pre-emptive Analgesia?   [更多]

求購(gòu)磷酸西格列汀片信息   [更多]

高價(jià)求《云南省中藥飲片標(biāo)準(zhǔn)》葛根粉云信息，如果你有標(biāo)準(zhǔn)，請(qǐng)聯(lián)系我，價(jià)格可談   [更多]

文獻(xiàn)標(biāo)題以及其它信息 1：ass Dermatol Sifilogr. 1961 Nov-Dec;14:283-94. [The intravenous use of lysozyme in the pain caused by cancer and first observations concerning the pharmacological combinations].[Article in Italian]SCOLARI EG, NANNELLI M, VALLECCHI C. PMID: 13909883 2：Minerva Medicoleg. 1963 Sep-Oct;83:130-4. [2 FATAL CASES CAUSED BY THE 1ST INTRAMUSCULAR INJECTION OF LYSOZYME]. [Article in Italian]LUVONI R. PMID: 14116728 3：Minerva Med. 1963 Apr 11;54:1016-21. [Lysozyme used by the intraarticular route in chronic arthrosynovitis. Clinical observations]. [Article in Italian]BRUNELLI G, POGGI AE. PMID: 1401627 4：Blade-Font, Artur; Rocabayera, Teodoro de Mas - [Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, p. 841 - 848] 5：Yoshida; Sato; Moroi - [Arzneimittel-Forschung/Drug Research, 1993, vol. 43, # 5, p. 601 - 606] 備注：提供PDF電子檔原件   [更多]

求購(gòu)達(dá)托霉素信息   [更多]

具體形式為填寫調(diào)查問(wèn)卷 要求： 1.醫(yī)藥行業(yè)從業(yè)人員 2.醫(yī)學(xué)院學(xué)生 3.醫(yī)生 通過(guò)在線調(diào)研后會(huì)被我們藥智匯備案為科研調(diào)研人員，任何調(diào)研項(xiàng)目?jī)?yōu)先通知。 投稿后添加QQ群：905763758，問(wèn)卷鏈接以及注意事項(xiàng)都在群里   [更多]